Researchers from the University of Birmingham (Birmingham, UK) and Newcastle University (Newcastle, UK) have investigated a key enzyme utilized by gut bacteria that could be developed as a biomarker for intestinal diseases.
Charles River (MA, USA) have acquired Cellero (MA, USA) in a bid to enhance their cell therapy market solutions.
I have the great pleasure to announce that the 24th Reid International Bioanalytical Forum will be…
PerkinElmer, Inc. (MA, USA) have described their technology and research solutions available to their global customers in the fight against COVID-19.
A team from Martin Luther University Halle-Wittenberg (MLU; Halle, Germany) have developed a mass spectrometry method reportedly successful at detecting minute quantities of SARS-CoV-2 in patient gargle solutions. This method could potentially assist existing COVID-19 diagnostic tests.
A team from Tokyo University of Science (Japan) have developed a fully automated micro-chip that can rapidly determine a patient’s blood type within 5 minutes. This holds great potential for use in emergency medical situations.
Researchers Julius-Maximilians-Universität (JMU; Würzburg, Germany), the University of Geneva (Geneva, Switzerland) and Monash University (Melbourne, Australia) have been able to create fluorescence imagining with molecular resolution to image cell structures, for the first time, by combining two previously incompatible microscopy methods.
SCIEX (MA, USA), a global leader in life science analytical technology, recently announced the launch of the next generation of their flagship nominal mass spectrometer, the SCIEX Triple Quad™ 7500 LC-MS/MS System – QTRAP® Ready.
Trajan Scientific and Medical (Melbourne, Australia) has listed its hemaPEN® blood microsampling device with the US FDA as Class I for therapeutic and in vitro diagnostic use.
A team from The University of Texas at Austin (TX, USA) are developing a sensor capable of testing for COVID-19 and influenza simultaneously.